Q-Line Biotech IPO Allotment Date
As per the timeline, the Q-Line Biotech IPO allotment date is May 26, 2026, Tuesday. The investors can check the IPO allotment via the registrar website of PurvaShare or the NSE website. Investors can check the allotment status online and offline with easy steps given below:
Q-Line Biotech IPO Allotment Links
| Registrar: | PurvaShare IPO Allotment Page |
| NSE: | NSE IPO Allotment Page |
| IPO Watch: | IPO Allotment Status Page |
Check Q-Line Biotech’ IPO Allotment Status on Registrar site?
- Visit Purva Sharegistry (India) Pvt. Ltd. website
- Select IPO Name ‘Q-Line Biotech’ from the drop-down menu on the page
- Enter details required like PAN Card, Application Number, or Demat Account Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Q-Line Biotech IPO Allotment Status on NSE?
- Visit NSE India IPO Allotment Page
- Select the issue type
- Select IPO Name ‘Q-Line Biotech’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
IPO Subscription Details
| Category | Day 1 | Day 2 | Day 3 |
| QIB | 4.15 | 5.19 | 123.94 |
| NII | 3.98 | 15.61 | 145.98 |
| RII | 2.93 | 10.01 | 71.44 |
| Total | 3.51 | 9.83 | 102.42 |
Q-Line Biotech IPO Key Dates
| IPO Open Date: | May 21, 2026 |
| IPO Close Date: | May 25, 2026 |
| Basis of Allotment: | May 26, 2026 |
| Refunds: | May 27, 2026 |
| Credit to Demat Account: | May 27, 2026 |
| IPO Listing Date: | May 29, 2026 |
Business Overview
Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range.
Q-Line Biotech has over 15 years of experience in the diagnostic industry and has served 150+ national and international clients. Moreover, the company also has 12 years of experience in developing and manufacturing various products. Its product range includes haematology, POC testing, clinical chemistry, molecular diagnostics, rapid tests, ELISA, and special diagnostics.
Note for the Investors
Q-Line Biotech IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Q-Line Biotech IPO Allotment date and time please contact the registrar with your queries.
